Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network
Clinical Pharmacology & Therapeutics · 07.11.2026
DOI: 10.1002/cpt.70553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 07.11.2026. Verfasst von Laura B Ramsey und 15 weiteren Autor:innen. Beteiligte Einrichtung: Children's Mercy Kansas City and University of Missouri-Kansas City, Kansas City, Missouri, USA. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Descriptions of how pediatric‐focused institutions implement pharmacogenomic testing are scarce, and often not differentiated from adult‐focused institutions. We aimed to provide a detailed description of how pediatric‐focused institutions across the world implemented pharmacogenomic testing in clinical practice. A survey was distributed to members of the Pharmacogenomics Global Research Network to assess program infrastructure, implementation efforts, genes tested, method of testing, and clinical decision support. The survey was completed by 43 institutions that have implemented pharmacogenomics: 12 pediatric‐focused, 10 adult‐focused, and 21 institutions serving all ages. All pediatric‐focused institutions provide testing for CYP2C19 , CYP2C9 , CYP2D6 , CYP3A5 , NUDT15 , and TPMT . Psychiatry and hematology/oncology were the specialties most commonly reported as implementing pharmacogenomics at pediatric‐focused institutions. Most institutions have clinical decision support incorporated into their electronic health record and a similar number of compensated employees contributing to the program, regardless of age group focus. All pediatric‐focused institutions were non‐profit and often received programmatic funding from internal sources. A higher proportion of pediatric‐focused sites provided patient education (92%) compared to adult‐focused (60%) and those caring for all ages (76%). Pediatric‐focused institutions interested in implementing or expanding their pharmacogenomic services will encounter many of the same opportunities and considerations as adult institutions. The results of this survey highlight additional unique considerations for pediatric‐focused pharmacogenomic implementation and may serve as a roadmap for pediatric institutions interested in implementing or expanding pharmacogenomic services.
Autor:innen und Institutionen
- Children's Mercy Kansas City and University of Missouri-Kansas City, Kansas City, Missouri, USA.
- Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
- St. Louis Children's Hospital, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
- University of Florida College of Pharmacy and Nemours Children's Health, Jacksonville, Florida, USA.
- Children's Minnesota, Minneapolis/St. Paul, Minnesota, USA.
- Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Laura B Ramsey, Chad Bousman, Kelsey Cook, David B Gregornik, Cyrine E Haidar, Nancy Hakooz, Nicole Keuler, Nathan Lamb, Mohamed Nagy, Jenny Q Nguyen, Courtney Paetznick, D Max Smith, Evangelia Eirini Tsermpini, Amanda L Elchynski
Zitieren
APA
Ramsey, L. B., Bousman, C., Brand, R., Cook, K., Gregornik, D. B., Haidar, C. E., Hakooz, N., Keuler, N., Lamb, N., Nagy, M., Nguyen, J. Q., Paetznick, C., Schultz, A., Smith, D. M., Tsermpini, E. E., & Elchynski, A. L. (2026). Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70553
Vancouver
Ramsey LB, Bousman C, Brand R, Cook K, Gregornik DB, Haidar CE, et al. Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70553
BibTeX
@article{Ramsey2026,
author = {Ramsey, Laura B and Bousman, Chad and Brand, Rebecca and Cook, Kelsey and Gregornik, David B and Haidar, Cyrine E and Hakooz, Nancy and Keuler, Nicole and Lamb, Nathan and Nagy, Mohamed and Nguyen, Jenny Q and Paetznick, Courtney and Schultz, April and Smith, D Max and Tsermpini, Evangelia Eirini and Elchynski, Amanda L},
title = {Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network},
journal = {Clinical Pharmacology & Therapeutics},
year = {2026},
doi = {10.1002/cpt.70553}
}
EUVIMED